Published in Cell Mol Neurobiol on December 01, 2009
Is the CCR5 Δ 32 mutation associated with immune system-related diseases? Inflammation (2013) 0.91
The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations. Iran J Basic Med Sci (2015) 0.77
CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients. Mult Scler Int (2011) 0.76
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell (1996) 17.81
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med (2004) 8.98
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Chemokines and disease. Nat Immunol (2001) 5.62
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07
Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 2.50
Association between functional polymorphism in EGF gene and malignant melanoma. Lancet (2002) 2.48
Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol (1997) 1.79
Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol (1998) 1.72
Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler (2005) 1.46
Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler (2004) 1.45
Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol (2000) 1.13
The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol (1997) 1.00
A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology (2006) 0.97
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics (2000) 0.95
CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol (2000) 0.94
CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. J Neuroimmunol (2005) 0.92
Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol (2005) 0.91
Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients. Ann Neurol (2000) 0.89
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology (2002) 0.88
Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Clin Exp Immunol (2006) 0.87
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis. J Neurovirol (1999) 0.86
A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology (2003) 0.81
Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. Acta Neurol Scand (2004) 0.80
No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients. Mult Scler (2006) 0.78
Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis. Neurogenetics (2007) 0.76
Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros (2007) 1.21
Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. Pak J Biol Sci (2007) 0.97
Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care (2013) 0.92
Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis. Pathol Oncol Res (2005) 0.90
Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations. J Neurol Sci (2013) 0.85
Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran J Allergy Asthma Immunol (2006) 0.85
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease. Cell J (2012) 0.83
Effect of intrauterine morphine sulfate exposure on cerebellar histomorphological changes in neonatal mice. Folia Neuropathol (2011) 0.83
Investigation of CD24 and its expression in Iranian relapsing-remitting multiple sclerosis. Int J Neurosci (2011) 0.82
Investigation The Role of Gender on The HLA-DRB1 and -DQB1 Association with Type 1 Diabetes Mellitus in Iranian Patients. Cell J (2013) 0.82
Unilateral hypoglossal nerve palsy: as the only presentation of tuberculosis. Acta Med Iran (2012) 0.81
Detection of Duchenne/Becker muscular dystrophy carriers in a group of Iranian families by linkage analysis. Acta Med Iran (2011) 0.80
High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. Clin Immunol (2010) 0.78
Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Clin Immunol (2011) 0.78
Secondary chromosomal abnormalities of de novo acute myeloid leukemia--a first report from the Middle East. Asian Pac J Cancer Prev (2011) 0.77
Interferon-gamma gene polymorphism in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol (2004) 0.77
Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer's disease. Dement Geriatr Cogn Disord (2013) 0.76
Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis. Iran J Immunol (2017) 0.75
Ultra-wideband high-speed Mach-Zehnder switch based on hybrid plasmonic waveguides. Appl Opt (2017) 0.75
Middle Cerebral Artery, Ophthalmic Artery, and Multibranch Retinal Vessel Occlusion After Cosmetic Autologous Fat Transfer to Forehead. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
Dielectric metalenses with engineered point spread function. Appl Opt (2017) 0.75
An integrated photogrammetric and spatial database management system for producing fully structured data using aerial and remote sensing images. Sensors (Basel) (2009) 0.75
Reciprocal 22q11.2 Deletion and Duplication in Siblings with Karyotypically Normal Parents. Cytogenet Genome Res (2016) 0.75
Clinical Evidence of Decreased Iris Resistance in Patients With Keratoconus. Cornea (2016) 0.75
Can we rely on public data as a source of information for cancer registry in developing countries? Turk J Gastroenterol (2005) 0.75
Best disease associated with macular hole. Retin Cases Brief Rep (2015) 0.75
Trellis-based feed-forward carrier recovery for coherent optical systems. Opt Express (2016) 0.75
Sulfur mustard-induced ocular injuries: Update on mechanisms and management. Curr Pharm Des (2016) 0.75